272 PD-L1 CAR engineered K-NK cells to target PD-L1+ or PD-L1- tumors

• Pedro Romero,
• Andre Kunert,
• Hardikkumar Jetani,
• Katarzyna Franciszkiewicz,
• David Vlerick,
• Aleksandra Nowicka,
• Robert Y Igarashi

Affiliations

Pedro Romero

1Sanofi Pharma, Amsterdam, Netherlands

Andre Kunert

1Sanofi Pharma, Amsterdam, Netherlands

Hardikkumar Jetani

1Sanofi Pharma, Amsterdam, Netherlands

Katarzyna Franciszkiewicz

2Sanofi, Paris, Île-de-France, France

David Vlerick

3Sanofi, Ghent, East Flanders, Belgium

Aleksandra Nowicka

4Sanofi, Cambridge, MA, USA

Robert Y Igarashi

1Sanofi Pharma, Amsterdam, Netherlands